Skip Navigation

European Heart Journal 1986 7(10):848-858;
Copyright © 1986 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by SIMONETTI, I.
Right arrow Articles by L'ABBATE, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SIMONETTI, I.
Right arrow Articles by L'ABBATE, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1986 The European Society of Cardiology

Dose–response scrutiny of coronary vasodilation after intracoronary verapamil in man. A quantitative cineangiographic study

I. SIMONETTI, M. G. TRIVELLA, C. MICHELASSI, O. PARODI, D. M. DE NES and A. L'ABBATE

C.N.R. Clinical Physiology Institute and Istituto di Patologia Medica of the University of Pisa Italy

revised 18 March 1986; accepted 20 September 1985.

Address for correspondence: Ignazio Simonetti, MD, CNR Institute of Clincial Physiology, via Savi 8,56100 Pisa, Italy.

Abstract

The effect of various doses of intracoronary verapamil on the diameter of angiographically normal left coronary artery segments was investigated in 22 patients with and without coronary atherosclerosis by quantitative angiography. Very low doses (50 µg) were given in 3 patients; doses of 250 µg, 350 µg and 500 µg were administered in 7,6 and 13 patients, respectively. A single dose was administered in 15 patients, while two increasing doses of verapamil were tested in 7. The effect of verapamil was compared in each patient with that of nitroglycerin (NG; 0.6 mg), administered sublingually in all as the last step of the study.

An additional group of 8 patients served as the control. These patients received 4 intracoronary injections of contrast medium without drugs and a fifth injection following 0.6 mg of sublingual NG.

In the control group no significant changes in coronary artery diameter were observed following the four control injections of contrast medium, while a 18±9% increase in vascular diameter was observed following NG. When verapamil was injected a dose-dependent vasodilation was observed, which began to be significant with doses higher than 250 µg. Mean percent variations of coronary artery diameter relative to control were –0·2±3.6%, 4.6±5.5%, 11.4±7.5% and 19.9±10.7%, in response to verapamil doses of 50, 250, 350 and 500 µg, respectively. Subsequent nitroglycerin induced a 21.5±10.7% mean percent coronary artery dilation (NSvs verapamil 500 µg and vs NG in the controlgroup). Thus, verapamil induced a dose-dependent coronary vasodilation which at a dose of 500 µg was comparable to that induced by NG. Both with verapamil and NG the smallest vessels exhibited the greatest vasodilation. It is concluded that at the doses used in this study, injection of verapamil into the left coronary artery is safe and markedly decreases tone in the large coronary arteries. This finding supports the use of verapamil in clinical conditions in which the role of coronary vasoconstriction proven or thought to be relevant.

Key Words: Verapamil • nitroglycerin • quantitative angiography


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.